Sensation, Motion, and Quality of Life on Natalizumab and Off Natalizumab
Clinical trial NCT05172466 · WITHDRAWN
Trial details
- NCT number
- NCT05172466
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- WITHDRAWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2022-11-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.